JD three-lens brief
Evidence-based stock research on JD. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +2.67% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved +2.67% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Analyst mean target $39.95 — 40% above current (35 analysts).
JD closed at $28.48 (+2.67%) as of 2026-07-10. Market cap: $38.46B. P/E (trailing) 20.9. Price is below the 50-day MA and below the 200-day MA. Positives: moved +2.67% yesterday.; analyst mean target $39.95 — 40% above current (35 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $315.69B, net income $5.10B, free cash flow $7.01B.
Why three lenses on JD, not one.
A single reasoning model has blind spots it doesn’t know about. We examine JDacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/JD" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath JD brief"></iframe>